Suppr超能文献

检测力度变化对印度次大陆内脏利什曼病控制的影响。

Impact of Changes in Detection Effort on Control of Visceral Leishmaniasis in the Indian Subcontinent.

机构信息

Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.

Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Basel, Switzerland.

出版信息

J Infect Dis. 2020 Jun 11;221(Suppl 5):S546-S553. doi: 10.1093/infdis/jiz644.

Abstract

BACKGROUND

Control of visceral leishmaniasis (VL) on the Indian subcontinent relies on prompt detection and treatment of symptomatic cases. Detection efforts influence the observed VL incidence and how well it reflects the underlying true incidence. As control targets are defined in terms of observed cases, there is an urgent need to understand how changes in detection delay and population coverage of improved detection affect VL control.

METHODS

Using a mathematical model for transmission and control of VL, we predict the impact of reduced detection delays and/or increased population coverage of the detection programs on observed and true VL incidence and mortality.

RESULTS

Improved case detection, either by higher coverage or reduced detection delay, causes an initial rise in observed VL incidence before a reduction. Relaxation of improved detection may lead to an apparent temporary (1 year) reduction in VL incidence, but comes with a high risk of resurging infection levels. Duration of symptoms in detected cases shows an unequivocal association with detection effort.

CONCLUSIONS

VL incidence on its own is not a reliable indicator of the performance of case detection programs. Duration of symptoms in detected cases can be used as an additional marker of the performance of case detection programs.

摘要

背景

印度次大陆内脏利什曼病(VL)的控制依赖于对有症状病例的及时发现和治疗。检测工作影响了观察到的 VL 发病率,以及它在多大程度上反映了潜在的真实发病率。由于控制目标是根据观察到的病例来定义的,因此迫切需要了解检测延迟的变化和改进检测的人口覆盖率如何影响 VL 控制。

方法

我们使用 VL 传播和控制的数学模型来预测减少检测延迟和/或提高检测计划的人口覆盖率对观察到的和真实的 VL 发病率和死亡率的影响。

结果

无论是通过更高的覆盖率还是减少检测延迟,改进的病例检测都会导致观察到的 VL 发病率最初上升,然后才会下降。放松改进的检测可能会导致 VL 发病率暂时(1 年)下降,但存在感染水平再次上升的高风险。检测到的病例的症状持续时间与检测工作有明确的关联。

结论

VL 发病率本身并不是病例检测计划性能的可靠指标。检测到的病例的症状持续时间可以作为病例检测计划性能的附加指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16ae/7289545/1ffd74638c48/jiz644f0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验